Redirect Notice

Looks like you clickedhttps://www.globenewswire.com/news-release/2021/03/02/2184873/0/en/argenx-Announces-FDA-Acceptance-of-BLA-Filing-for-Efgartigimod-for-the-Treatment-of-Generalized-Myasthenia-Gravis.html

If you do not want to visit that page, you can close this browser tab.